Aberdeen Wealth Management »

Regeneron Pharmaceuticals shares owned by Aberdeen Wealth Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Aberdeen Wealth Management from 13F filings

Historical chart of Aberdeen Wealth Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Aberdeen Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Aberdeen Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $264k 300 878.29
2023-09-30 $247k 300 822.96
2023-06-30 $216k 300 718.54
2023-03-31 $247k 300 821.67
2022-12-31 $253k 350 721.49
2022-09-30 $241k 350 688.57
2022-06-30 $207k 350 591.43
2022-03-31 $244k 350 697.14
2021-12-31 $221k 350 631.43
2021-09-30 $227k 375 605.33
2021-06-30 $209k 375 557.33
2020-06-30 $225k 361 623.27
2020-03-31 $217k 445 487.64